头孢吡肟每日暴露与重症患者序贯器官衰竭评估评分变化及升压药需求的相关性:重复测量混合效应模型分析
本研究为回顾性研究,纳入接受头孢吡肟治疗革兰阴性菌肺炎或血流感染的成人ICU患者,分别有394例和207例进入SOFA评分和升压药分析。采用重复测量混合效应模型评估每日头孢吡肟药代动力学/药效学参数与每日SOFA评分变化及升压药需求的关系。结果显示,头孢吡肟浓度在100%给药间期内高于最低抑菌浓度(T>MIC)与去甲肾上腺素当量剂量降低0.006 µg/kg/min相关,但对SOFA评分日变化无影响。作者认为,达到100% T>MIC与升压药需求降低幅度可忽略相关。
要点
- 在革兰阴性菌肺炎或血流感染成人ICU患者中,头孢吡肟达到100% T>MIC与去甲肾上腺素当量剂量降低0.006 µg/kg/min相关。
- 头孢吡肟PK/PD参数对每日SOFA评分变化无影响。
- SOFA分析纳入394例,升压药分析纳入207例;平均年龄55岁(标准差19),平均体重81 kg(标准差29)。
- SOFA变化模型最终纳入每日SOFA评分、机械通气、肾脏替代治疗和升压药数量。
- 升压药模型最终纳入每日SOFA评分、治疗天数和氢化可的松剂量作为显著协变量。
适用人群与场景
- 接受头孢吡肟治疗革兰阴性菌肺炎或血流感染(BSI)并测量了头孢吡肟浓度的成人ICU患者。
研究设计与关键结果
- 研究类型为回顾性研究,SOFA分析纳入394例,升压药分析纳入207例;平均年龄55岁(标准差19),平均体重81 kg(标准差29)。
- SOFA评分变化分析中,每日SOFA评分、机械通气、肾脏替代治疗和升压药数量被纳入模型。
- 升压药分析中,每日SOFA评分、治疗天数和氢化可的松剂量为最终模型中的显著协变量。
- 头孢吡肟浓度在100%给药间期内高于MIC(T>MIC)与去甲肾上腺素当量剂量降低0.006 µg/kg/min相关。
- 头孢吡肟PK/PD对每日SOFA评分变化无影响。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在革兰阴性菌肺炎和BSI的ICU患者中,达到100% T>MIC与升压药需求降低幅度可忽略相关,且对SOFA评分变化无影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Sepsis and septic shock are major healthcare problems that need early and appropriate management.
OBJECTIVES: To evaluate the association of daily cefepime pharmacokinetic/pharmacodynamic (PK/PD) parameters with change in Sequential Organ Failure Assessment (SOFA) score and vasopressors requirement.
DESIGN SETTING AND PARTICIPANTS: This is a retrospective study. Adult ICU patients who received cefepime for Gram-negative pneumonia or bloodstream infection (BSI) and had cefepime concentrations measured were included. Daily cefepime exposure was generated and PK/PD parameters calculated for patients. Repeated-measures mixed-effect modeling was used to evaluate the impact of PK/PD on the outcomes.
MAIN OUTCOMES AND MEASURES: Change in daily SOFA score and vasopressors requirement.
RESULTS: A total of 394 and 207 patients were included in the SOFA and vasopressors analyses, respectively. The mean (±sd) age was 55 years (19) and weight 81 kg (29). For the change in SOFA score, daily SOFA score, mechanical ventilation, renal replacement therapy, and number of vasopressors were included. In the vasopressors analysis, daily SOFA score, day of therapy, and hydrocortisone dose were significant covariates in the final model. Achieving cefepime concentrations above the minimum inhibitory concentration (MIC) (T>MIC) for 100% of the dosing interval was associated with 0.006 µg/kg/min decrease in norepinephrine-equivalent dose. Cefepime PK/PD did not have an impact on the daily change in SOFA score.
CONCLUSIONS AND RELEVANCE: Achieving 100% T>MIC was associated with negligible decrease in vasopressors requirement in ICU patients with Gram-negative pneumonia and BSI. There was no impact on the change in SOFA score.
参考来源
- Alshaer MH, Williams R, Mousa MJ, et al. Cefepime Daily Exposure and the Associated Impact on the Change in Sequential Organ Failure Assessment Scores and Vasopressors Requirement in Critically Ill Patients Using Repeated-Measures Mixed-Effect Modeling. Crit Care Explor. 2023. PMID: 38304706. doi:10.1097/CCE.0000000000000993
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。